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Abstract 
 Activity of the human long interspersed nuclear elements-1 (LINE-1) 
retrotransposon occurs mainly in early embryonic development and during 
hippocampal neurogenesis. SOX-11, a transcription factor relevant to neuronal 
development, has unknown functions in the control of LINE-1 retrotransposon activity 
during neuronal differentiation. To study the dependence of LINE-1 activity on SOX-
11 during neuronal differentiation, we induced differentiation of human SH-SY5Y 
neuroblastoma cells and adult adipose mesenchymal stem cells (hASCs) to a 
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neuronal fate and found increased LINE-1 activity. We also show that SOX-11 
protein binding to the LINE-1 promoter is higher in differentiating neuroblastoma 
cells, while knock-down of SOX-11 inhibits the induction of LINE-1 transcription in 
differentiating conditions. These results suggest that activation of LINE-1 
retrotransposition during neuronal differentiation is mediated by SOX-11. 
 
1. Introduction 
 The LINE-1 (long interspersed nuclear element 1) retrotransposon family is 
composed of repetitive elements present in mammalian genomes, capable of 
synthesizing DNA from self-RNA intermediary templates, and comprises17 % of the 
human genome. LINE-1 retrotransposons contain a 5´untranslated region and two 
sequences: one encoding a nucleic acid binding protein and the other an 
endonuclease with reverse transcriptase activity (Orf1p and Orf2p, 
respectively).They also contain an ORF0 sequence with anti-sense orientation, with 
a promoter capable of driving the synthesis of fusion proteins [1-4]. More than 80-
100 transcriptionally active copies of LINE-1 have been described in the human 
genome [5, 6] and 3000 active copies in the mouse genome [7]. 
 The process of LINE-1 retrotransposition occurs in cells with high pluripotency and 
during early stages of neural development, such as in mouse and human embryonic 
stem cells (ESC) [8, 9], human reprogrammed induced pluripotent stem cells (iPSC) 
[10, 11], differentiated neuroblastoma cells [12], and neural progenitor cells 
differentiating into neurons [13], among other types of cells. 
 Previous studies have demonstrated that LINE-1 elements can alter gene 
expression through mutations caused by insertions within genes, or by chromatin 
remodeling driven by insertions within or near genes [14]. Thus, it has been 
postulated that different numbers of LINE-1 copies (or quality of insertions) lead to 
cells with different gene expression patterns [15]. In the case of neurons, variation in 
the quantity and quality of LINE-1 insertions can lead to mosaicism and different 
neural identity [16]. 
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 The mechanisms that control LINE-1 expression are not completely understood, 
although DNA hypermethylation in CpG sequences in the 5´UTR has been reported 
as a process that downregulates LINE-1 retrotransposition [17]. Interestingly, MeCP2 
was shown to repress LINE-1 activity by interacting with methylated sequences [18]. 
Yet, other mechanisms regulating LINE-1 activity have also been described: 
APOBEC3 cytidine deaminases were shown to restrict LINE-1 mobilization [19], 
while small interfering and piwi interacting RNAs are also believed to control 
expression [20]. Recently, it has been shown that mobilization of LINE-1 
retrotransposons is restricted in mouse ESC by Tex19.1, a protein that directly 
interacts with ORF1p, stimulating its polyubiquitylation and later degradation [21]. 
 The sex determining region Y-box 11(SRY-11) gene, also known as SOX-11, is a 
SOX-C gene family member that encodes a transcription factor involved in 
neurogenesis and tissue remodeling during embryogenesis, among other processes 
[22]. SOX-11 expression is necessary for neurite outgrowth and neuron survival [23]. 
Interestingly, two SOX-11 binding sites have been described in the LINE-1 promoter, 
as shown by electrophoretic mobility shift assay, while over-expression of exogenous 
SOX-11 increases LINE-1 promoter activity [24]. 
 Due to the capacity forLINE-1 retrotransposition in neuronal progenitor cells, we 
investigated the role of SOX-11 in the activation of LINE-1 elements during neuronal 
differentiation. We chose as a well established and commonly used neuronal 
differentiation model the neuroblastoma cell line SH-SY5Y, and also human adipose-
derived stem cells (hASCs), a multipotent cell type with promising potential in 
regenerative medicine due to its capacity to differentiate into a wide variety of tissues 
[25, 26]. 
 
2. Materials and methods 
2.1. Cell culture and Neuronal differentiation 
 SH-SY5Y cells were cultured in DMEM/F12 (Gibco) supplemented with 10 % fetal 
bovine serum (FBS, Gibco) and 100 U/ml penicillin, 100 μg/ml streptomycin, and 
0.25 μg/ml amphotericin B (Gibco). HeLa and 293T cells were cultured in DMEM 
supplemented with FBS and antibiotics. Differentiation ofSH-SY5Y cell line was 
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achieved with 10 M retinoic acid (RA, Sigma) in DMEM/F12 containing 1 % FBS 
[27]. Neuronal differentiation was confirmed with neurite outgrowth assays with 
ImageJ 1.50i (Rasband, W., National Institutes of Health, USA), with positive cells 
showing a neurite/soma ratio of 1.5 or higher. 
 hASCs were obtained as described elsewhere [28] after informed consent and 
approval of the Ethics Committee of Research Protocols from Hospital Italiano de 
Buenos Aires, and cultured in DMEM with 20 % FBS, 100 U/ml penicillin, 100 g/ml 
stremptomycin and 0.25 g/ml amphotericin B. Neuronal differentiation of passages 
3 to 5 subconfluent cells was achieved with a preinduction of 48 h with growth 
medium and 1 mM -mercaptoethanol followed by induction with 100 M butylated 
hydroxyanisole (BHA, Sigma), 1 M RA, 10 ng/ml epidermal growth factor (EGF, 
Invitrogen, Brazil), and 10 ng/ml basic fibroblast growth factor (bFGF, Invitrogen) in 
DMEM during 14days, changing medium every 3 days [28]. 
 
2.2. RNA interference 
 50 pmol short interfering RNA (siRNA) targeting SOX-11 (siRNA SOX11 pair #1 
sense, GUCGCUGGUGGAUAAGGAUTT; anti-sense, 
AUCCUUAUCCACCAGCGACAG; siRNA SOX11 pair #2 sense, 
GACCUGAUGUUCGACCUGATT; anti-sense, UCAGGUCGAACAUCAGGUCGT; or 
scrambled siRNA (Invitrogen) were transfected with Lipofectamine 2000 (Invitrogen) 
in Optimem in SH-SY5Y cells for 24 h. After other 24 h incubation in growth medium, 
cells were treated with 10 M RA in differentiation medium or with vehicle in growth 
medium for 48 h. 
 
2.3. Transient transfections and luciferase assay 
 100,000 SH-SY5Y cells plated in 12-well plates with antibiotic-free medium were 
transfected overnight with 4g pL1.3-Luc plasmid (kindly provided by Dr G. 
Shumann), 4g -galactosidase control plasmid and 8g polyethylenimine (Sigma). 
Next, cells were incubated in growth medium for 8 h and treated with RA. After 48 h, 
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luciferase activity was measured by chemoluminiscence (Promega) and normalized 
to -galactosidase activity. 
 
2.4. DNA and RNA extraction 
 Genomic DNA was isolated using a QIAmp DNA Blood mini kit (Qiagen, Hilden, 
Germany) following the manufacturer’s protocol. Total RNA was extracted with Trizol 
reagent (Invitrogen) according to the manufacturer’s instructions. 
 
2.5. Real time RT-qPCR 
 RNA samples were first digested with RQ I DNase (Promega) according to 
manufacturer´s instructions. For reverse transcription, 1 μg of total RNA was used. 
Unless otherwise stated, the first cDNA strand was synthesized using ImProm-II 
Reverse Transcription System (Promega) and oligo(dT), according to manufacturer´s 
instructions. RNA was also retro-transcribed with random hexamers following 
manufacturer´s instructions. For the quantitative real-time RT-PCR (RT-qPCR), 1 μl 
cDNA (10-fold diluted) or 8 ng of genomic DNA were used. All reactions were 
conducted in a volume of 20 μl using LightCycler FastStart DNA Master SYBR 
Green I kit (Roche) in a LightCycler® 2.0 equipment (Roche). The oligonucleotides 
used for LINE-1 were reported by Coufal et al. (2009) [16], using the L1 database 
(http://l1base.charite.de). Sequences used were as follows: LINE-1-fw, 
TGCGGAGAAATAGGAACACTTTT; LINE-1-rev, TGAGGAATCGCCACACTGACT; 
SOX-11-fw, GGAGAGCTTGGAAGCGGAGA; SOX-11-rev, 
CAAGCCATGAATTCGCCCTC; RNA 5S-fw, CTCGTCTGATCTCGGAAGCTAAG; 
RNA 5S-rev, GCGGTCTCCCATCCAAGTAC; ACTIN-fw, 
CCCTTGCCATCCTAAAAGCC; ACTIN-rev, TGCTATCACCTCCCCTGTGT; LINE-1 
3´ region-fw: CAAACACCGCATATTCTCACTCA; LINE-1 3´ region-rev: 
CTTCCTGTGTCCATGTGATCTCA; LINE-1 5´ region-fw: 
ACAGCTTTGAAGAGAGCAGTGGTT; LINE-1 5´ region-rev: 
AGTCTGCCCGTTCTCAGATCT. 
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 Reactions were run for 40 cycles under the following conditions: 10 s at 94 °C, 10 
s at 58-60 °C (according to the primers), and 10 s at 72 °C. The amplification of 
unique products in each reaction was verified by melting curve and ethidium bromide 
(Sigma)-stained agarose gel electrophoresis. The expression level of each gene was 
normalized to ACTIN or RNA 5S expression levels, using standard curve methods 
based on serial dilutions or known amounts of DNA, respectively. 
 
2.6. Chromatin immunoprecipitation (ChIP) 
 ChIP assays were performed as described previously [29, 30]. Briefly, chromatin 
was sonicated to an average of about 500 bp. Sonicated chromatin was then 
immunoprecipitated by using 2 µg of anti-SOX11 antibody (Santa Cruz 
Biotechnologies) and IgG as a control. The immunoprecipitate was collected by 
using protein A agarose beads (Millipore), which were washed repeatedly to remove 
nonspecific DNA binding. The chromatin was eluted from the beads, and cross-links 
were removed by incubation overnight at 65 °C. DNA was then purified and 
quantified by real-time PCR using Applied Biosystems StepOnePlusTM (Thermo 
Scientific). Primers used were: primer pair 1: GGCTTGCTTGGGTAAACAAA 
(forward) and CAGTCTGCCCGTTCTCAGAT (reverse); primer pair 2: 
TGCAGCTGGAGATCTGAGAA (forward) and GGGTTTTTGGTGTGGATGTC 
(reverse). The fold enrichment of target sequence in the immunoprecipitated (IP) 
compared to input (Ref) fractions was calculated using the comparative Ct (the 
number of cycles required to reach a threshold concentration) method with the 
equation 2Ct(Ref)-Ct(IP). Each of these values was referred to as relative 
abundance. 
 
2.7. Statistical analysis 
 Student's t-tests, difference of proportions test or ANOVA followed by Tukey's 
multiple comparisons test were used to detect significant differences among 
treatments. Normality and homogeneity of variances were tested with Shapiro-Wilks 
and Levene´s tests, respectively. Statistical analyses were performed with Infostat 
(Di Rienzo,J.A., Casanoves, F., Balzarini, M.G., Gonzalez, L., Tablada, M., Robledo, 
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C.W. InfoStat versión 2011. Grupo InfoStat, FCA, Universidad Nacional de Córdoba, 
Argentina, http://www.infostat.com.ar). Differences were considered as significant if p 
< 0.05. Results are expressed as mean ± standard error of the mean (SEM) from at 
least three independent experiments. 
 
3. Results 
3.1. LINE-1 activity during neuronal differentiation 
 The mechanisms that control LINE-1 activity during neuronal differentiation remain 
poorly understood, although SOX-2 and YY1 transcription factors have been shown 
to modulate LINE-1retrotransposition [31]. Thus, we studied the involvement of SOX-
11 in the control of the activity of LINE-1 elements when neuroblastoma cell lines 
differentiate to polarized neuron-like cells. 
 Modulation of LINE-1 activity involves control of the transcription driving the 
synthesis of intermediary RNA molecules. To investigate this further, SH-SY5Y cell 
cultures were induced to differentiate into polarized neuronal cell type using10 M 
RA. After 48h, LINE-1 activity was quantified by RT-qPCR using primers targeting 
the Orf-2 sequence (Fig. 1A) and the housekeeping gene ACTIN. Interestingly, 
LINE-1 RNA levels normalized to ACTIN mRNA were significantly higher (37 %) in 
RA-treated cells than in control cells (Fig.1B), suggesting that LINE-1 RNA 
expression is increased during neuronal differentiation. 
 Because aberrant LINE-1 transcription may occur [32], RNA levels are usually 
measured by RT-qPCR using cDNA primed with oligo(dT) and primers targeting the 
Orf-2 sequence near the 3'-end of the transcript. To also rule out the possibility of 
truncated or prematurely polyadenylated LINE-1 RNA affecting the qPCR-based 
quantification, LINE-1 RNA was retrotranscribed with random hexamers and 
subjected to real time PCR with primers targeting the Orf-2 sequence and also 
sequences 5´and 3' from Orf-2 (Fig. 1A). Not surprisingly, we found similar results, 
showing that RA treatment significantly increases LINE-1 RNA levels (Fig. 1 C) 
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 Despite the significant difference, and due to the presence of many copies of the 
LINE-1 element, we determined whether transcript level variation corresponds to 
changes at the promoter level. Thus, neuroblastoma cells were transiently 
transfected with a reporter vector carrying a luciferase gene downstream of the 
active LINE-1 5´UTR sequence with promoter function [17], and then challenged with 
RA for 48 h. After differentiation cells were lysed and luciferase assayed. This 
experiment revealed a significant 3.7 folds increase in luciferase expression under 
control of the LINE-1 promoter after RA treatment in SH-SY5Y compared with control 
cells (Fig.1D). This result suggests that neuron-like differentiation induced by RA 
increases the promoter activity of LINE-1 elements. 
 After RNA transcription, LINE-1 elements are retrotranscribed and inserted into 
new genome sites; thus, if LINE-1 activity changes, the copy number of elements 
should vary. In order to determine changes in LINE-1 DNA during neuronal 
differentiation, as suggested by the changes in RNA levels and promoter activity, 
SH-SY5Y cells were treated with RA for 5 days (a longer period than that used for 
RNA synthesis to allow new insertions), DNA was extracted and the relative Orf-2 
DNA content was analyzed by qPCR and normalized to the RNA5S gene, indicative 
of the relative copy number of LINE-1 elements. As shown in Fig. 1E, relative Orf-2 
DNA content increased significantly (0.86 vs 1.53 relative Orf-2 DNA content, ≈1.78-
fold increase) upon RA induction. 
 Adipose-derived mesenchymal stem cells have a great potential in regenerative 
medicine because of their capacity to differentiate into a vast number of cell types, 
including neuronal cells. Protocols for neuronal differentiation of hASCs have been 
exhaustively detailed in reports from our laboratory and others, and show that 
neuron-like cells derived from hASCs exhibit neurite outgrowth and expression of 
neuronal markers [33-35]. Thus, we decided to evaluate whether LINE-1 elements 
are activated in a model of neuronal differentiation of hASCs. Interestingly we found 
that neuron-like cells derived from hASCs contain higher levels of LINE-1 RNA as 
compared to control non-differentiated hASCs (0.60 vs 1.44 RNA levels, ≈2.4-fold 
increase), as shown in Fig. 2 A. We then analyzed relative Orf-2 DNA content, and 
observed that LINE-1 endogenous levels also increase in differentiating conditions 
(1.00 vs 1.24 relative Orf-2 DNA content), consistent with RNA levels (Fig. 2 B). 
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 Thus, in neuron-like cells derived both from SH-SY5Y and hASCs, LINE-1 RNA 
levels are higher than in undifferentiated cells. To rule out the effects of RA on LINE-
1 activity in other cell types, LINE-1 RNA levels were determined in HeLa and 293T 
cells treated with RA. In these cells LINE-1 activity remained unchanged under RA 
challenge (Fig 2. C). 
 
3.2. SOX-11 expression increases during neuronal differentiation 
 SOX-C transcription factors are relevant for the development of the nervous 
system, and two SOX-11 binding sites have been previously described in the 5´UTR 
of LINE-1 of 293 and NTera-2 cells. Thus, we decided to test whether variations in 
SOX-11 expression during neuroblastoma cells differentiation can modulate LINE-1 
activity. 
 We first analyzed SOX-11 expression in SH-SY5Y cells undergoing differentiation 
with RA. SOX-11 mRNA levels quantified by RT-qPCR showed a significant increase 
(0.65 vs 1.75, ≈2.7-fold) in cells treated with RA for 24 h compared to control 
conditions (Fig. 3 A).This increase of SOX-11 RNA follows the process of SH-SY5Y 
differentiation, and mRNA levels remained high even at 72 h after incubation with RA 
(data not shown). 
 Next, we evaluated SOX-11 expression during differentiation of hASCs, 
measuring RNA levels in hASCs in control and differentiating conditions: Fig. 3 B 
shows that, similarly to our observations in SH-SY5Y cells, SOX-11 RNA levels are 
higher when cell are differentiated into neuron-like cells (1.9-fold). Thus, results 
obtained in hASCs strongly support that LINE-1 transcription is activated during 
neuronal differentiation, and that SOX-11 expression is induced. 
 
3.3. SOX-11 protein binds to the 5´UTR sequence in LINE-1 during neuronal 
differentiation 
 After showing that both LINE-1 and SOX-11 levels are increased under neuronal 
differentiation conditions, we tested whether SOX-11 binds to the 5´UTR of the 
human LINE-1 promoter. ChIP assays were performed using primers flanking two 
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SOX-11 binding sites observed in 3T3 and Ntera-2 cells [24], as illustrated in Fig. 4 
A. Quantification of ChIP assays revealed that LINE-1 promoter sequences are 
enriched in SOX-11 proteins in SH-SY5Y cells treated with RA for 24 h compared 
with control. Primer pair 1, targeting the first SOX-11 binding site in the LINE-1 
5´UTR, amplified a sequence enriched in SOX-11 proteins at higher levels in RA-
treated cells compared to control (2.46 folds increase), as shown in Fig. 4 B. On the 
other hand, SOX-11 enrichment in the second SOX-11 binding site with primer pair 2 
was also slightly higher in treated cells compared to control cells, although no 
significantly differences were observed. Specificity of this result is demonstrated with 
IgG control ChIP from RA-treated and control cells, with the latter showing levels 
similar to those of control cells (Fig. 4 B). Additionally, we amplified as a negative 
control a sequence located in the GREB1 gene known to not bind SOX-11. As 
expected, we did not observe recruitment of SOX-11 to this site neither in control 
cells nor in cells treated with RA. Moreover, the percentage of input was even lower 
than that obtained for the sites analyzed in the LINE-1 5’UTR (data not shown). The 
low percentage of input was probably due to the quantification method that 
compares input CT and immunoprecipitate CT: LINE-1 retrotransposons are over-
represented in the genome, and the values were determined according to the 
formula described in material and methods, thus conducting to low input CT when 
compared to CT obtained for other genes. However, values of GREB1 negative 
control were even lower (data not shown). 
 These data show that SOX-11 transcription factor recruitment to binding sites in 
the LINE-1 promoter is increased when neuroblastoma cells differentiate into 
neuron-like cells. 
 
3.4. SOX-11 expression regulates LINE-1 activity during neuronal differentiation 
 In order to assess the relevance of SOX-11 in the rise of LINE-1 activity during 
neuronal differentiation, we tested 2 pairs of siRNA duplexes, pair #1 and pair #2, 
that interfere SOX-11 expression. RT-qPCR analysis revealed that SOX-11 was 
efficiently knocked down in SH-SY5Y cells with pair #2 when compared to scramble 
control (Fig. 5 A), although RA retained the capacity to slightly augment LINE-1 
levels compared to siRNA-treated cells in non-differentiation conditions. Pair #1 
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yielded similar results with higher dispersion of values (data not shown). 
Interestingly, as shown in Fig. 5 B, the increase of LINE-1 RNA levels by RA, as 
observed by RT-qPCR, is lost when SOX-11 expression is inhibited (1.23 vs 0.41 
LINE-1 RNA levels), suggesting that SOX-11 is key for RA-induced LINE-1 activation 
during neuronal differentiation. 
 In this context, we also analyzed neurites outgrowth as a parameter of 
neurogenesis. Results show that the number of cells with neuron phenotype under 
RA treatment remained the same in cells transfected with control scramble RNA or 
siRNA against SOX-11 (Fig. 5 C), suggesting that high SOX-11 mRNA levels are not 
needed for the induction of neuronal differentiation. 
 Because of the large number of cells required for ChIP assays in hASCs and the 
difficulties of transfection in this cell type, neither ChIP nor siRNA experiments could 
be performed. However, results presented here suggest that during neuronal 
differentiation the expression of SOX-11 increases, allowing its binding to the LINE-1 
promoter and inducing LINE-1 retrotransposition. 
 
4. Discussion 
 The LINE-1 family is composed of a great number of copies in the genome, mostly 
non-functional. However, about 80 copies are active in the human genome, mainly in 
the germline and in early embryo cells. Thus, LINE-1 activity has been widely 
associated with the early stages of embryonic development. Noteworthy, ORF1 
expression has been observed in more than 40 % of human cancers [36], perhaps 
due to intrinsic endonuclease-driven tumorigenesis or mutagenic insertions [37, 38]. 
Importantly, repression of these elements in adult cells had been highlighted until 
LINE-1 retrotransposition was shown to occur in hippocampal neural progenitor cells 
[13]. However, mainly exogenous activity experiments have been addressed, as 
mainly reporter genes strategies were previously employed, while few reports 
combining both transfection assays and endogenous LINE-1 activity have been 
published such as the one describing LINE-1 retrotransposition in neural progenitor 
cells isolated from human fetal brain or derived from human embryonic stem cells 
[16]. 
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 In our study, we report that LINE-1 retrotransposition takes place when neuronal 
differentiation is induced with RA in neuroblastoma cells, based on the increase of 
LINE-1 RNA levels, Orf-2 DNA content, and LINE-1 promoter activity in RA-treated 
cells compared to basal conditions. Yet, we cannot rule out alterations in DNA 
content through mechanisms other than retrotransposition. The reason why LINE-1 
RNA, promoter activity and DNA content vary differentially upon RA treatment 
remains elusive. Apart from differences among the times of RA treatment used for 
each assay, it is known that LINE-1 mobilization is controlled by promoter DNA 
methylation [16], APOBEC proteins [39], the exonuclease Trex1 [21] and Piwi 
proteins and Piwi-interacting RNAs [40], all mechanisms that affect LINE-1 activity at 
the transcriptional and post-transcriptional levels. Thus, kinetics studies, also using 
other housekeeping genes, e.g. SATA, due to the difference in the number of 
repeats among them, and extra studies of molecular mechanisms underlying 
retrotransposition could shed light on this. 
 The literature describes several protocols for the differentiation of human SH-
SY5Y cells including phorbol esters such as 12-O-tetradecanoyl-phorbol-13 acetate 
or dibutyryl cyclic AMP, though RA has been widely used. These methods all trigger 
neurite outgrowth and expression of different neuronal markers in a time-dependent 
manner [41]. 
 Apart from analyzing LINE-1 activity in commonly used model of neuronal 
differentiation of SH-SY5Y, we evaluated LINE-1 activity during neuronal 
differentiation of hASCs, and found a significant increase in RNA levels and a slight 
augmentation of relative LINE-1 DNA content in neuron-like cells derived from hASC 
compared to control cells. These results support the idea of LINE-1 activation in cells 
that are induced to differentiate into neuronal types in vitro. It has been recently 
shown that mesenchymal stem cell types -hASCs, bone marrow, and umbilical cord, 
isolated from adult sources- have very low levels of LINE-1 expression and 
retrotransposition [42]. 
 Activity of LINE-1 was first described in proliferating early stages of development. 
Then, activity was observed in neuronal progenitors in the adult brain. Notably, LINE-
1 retrotransposition has been recently demonstrated in mature non-dividing human 
neurons: using a LINE-1 cassette reporter, Macia et al. (2017) demonstrated that 
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LINE-1 mobilization is not restricted to somatic neuronal precursor cells in the human 
brain, but also takes place in mature neurons [42], suggesting that the impact of 
LINE-1 retrotransposition in somatic mosaicism in the human brain could be higher 
than previously thought. 
 LINE-1 retrotransposition requires an RNA intermediate that is retro-transcribed, 
after which the DNA copy is inserted into new genome locations. Differential LINE-1 
activity in single neurons is believed to play a key role in brain mosaicism, with major 
effects on neuronal circuits and/or in determining neuron fate. However, in our study 
the identity of the LINE-1 elements retrotransposed and their localization in the 
genome remains to be established, a goal that could be achieved by the newly-
developed technique Single-cell retrotransposon capture sequencing [43]. This 
technology has shed light on LINE-1 mosaicism at genomic loci expressed in 
hippocampal neurons: in a report by Upton et al. (2015), approximately 13.7 somatic 
LINE-1 insertions per hippocampal neuron were identified [44]. The authors 
demonstrate also that hippocampal neuron LINE-1 insertions are enriched in 
transcribed neuronal stem cell enhancers and hippocampus genes. Taking this into 
account, LINE-1 activation during hASC differentiation towards the neuronal lineage 
could resemble retrotransposition in hippocampal neuronal progenitor cells. 
 LINE-1 activity is controlled by several described mechanisms. After early 
embryogenesis, retrotransposition is restricted in most tissues. Not surprisingly, 
promoter methylation triggering LINE-1 inactivation has been deeply studied; the 
5´UTR in the promoter contains a CpG island that is heavily methylated, and directs 
LINE-1 repression via binding of methyl-CpG-binding protein 2 (MeCP2) to 
methylated sequences [17]. Interestingly, a loss of function mutation affecting 
MeCP2 has been reported in Rett Syndrome, in which MeCP2-LINE-1 interaction is 
lost and high LINE-1 retrotransposition is observed [18]. 
 Interestingly, the LINE-1 promoters in the mesenchymal stem cells were shown to 
be highly methylated [42]. Thus, basal low LINE-1 activity in hASCs could be 
explained by a high methylation status in its promoter, while the neuronal 
differentiation program might elicit a methylation rearrangement, including 
demethylation of LINE-1 promoter and its activation. Preliminary data show that 
LINE-1 RNA levels increase in neuron-like cells derived from hASCs treated with 
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DNA methyl transferases inhibitor 5-azacytidine (unpublished results); it would thus 
not be surprising if the RA receptor, similarly to other nuclear receptors, could 
modulate gene expression by recruiting chromatin remodeling complexes to specific 
DNA sequences. 
 Tumors are another case exhibiting LINE-1 activity deregulation. It has recently 
been proposed that LINE-1 protein expression is one key feature of many human 
cancers: almost half of all human high-grade malignant cancers contain high levels 
of LINE-1 ORF1p, which is rarely detected in early stages of tumorigenesis and is 
absent from normal somatic tissues [45]. Furthermore, the literature shows an 
association between cancer, high LINE-1 activity and LINE-1 promoter 
hypomethylation, even proposing LINE-1 hypomethylation as an epigenetic marker 
for cancer risk [46, 47]. Interestingly, a recent report shows that LINE-1 knock-down 
impairs telomerase activity and a consequent decreased telomere length in tumor 
cells [48]. 
 SOX-11, a member of the SOX-C transcription factors family, is relevant to 
neuronal development and neurogenesis, being expressed mainly in neural cells that 
have already been committed to neuronal differentiation [49]. In the chick embryo, 
SOX-4 and SOX-11 activity is repressed by the transcriptional repressor protein 
REST/NRSF; upon differentiation SOX-4 and SOX-11 then function as 
transcriptional activators establishing pan-neuronal protein expression [50]. In the 
present study, we found that SOX-11 expression increases during neuronal 
differentiation of SH-SY5Y cells. Neuronal-like cells derived from hASCs also contain 
higher SOX-11 mRNA levels compared to control non-differentiated cells. 
Interestingly, we show that SOX-11 binds to LINE-1 promoter sequences in neuron-
like cells derived from SH-SY5Y cells, and that the inhibition of SOX-11 expression 
in neuroblastoma cells blocked LINE-1 activity during neuronal differentiation. These 
results highlight the importance of SOX-11 in neuronal differentiation. Notably, 
members of the SOX-C family share functions, so SOX-11 may act redundantly with 
SOX-4 and -12 [51]. 
 Our results show that, in spite of being necessary for LINE-1 transcription (as 
observed in SOX-11 knock-down assays), SOX-11 inhibition is not sufficient to 
repress neuronal differentiation of SH-SY5Y cells. It has been previously reported 
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that SOX-11 shares redundant functions with SOX-4 in neurogenesis in the mouse 
brain [52]. Thus, it seem possible that SOX-4 or -12 carry out functions in neuronal 
differentiation without affecting LINE-1 activity. However, we cannot exclude that 
SOX-4 and -12 bind LINE-1 sequences, or participate in the control of its 
retrotransposition. 
 Finally, SOX-11 and LINE-1 might be related to cancer. SOX-11 expression in 
chronic lymphocytic leukemia, among a number of human cancers, was shown to 
correlate with adverse prognostic markers such as Immunoglobulin heavy chain 
variable regionmutational status [53]. It seems possible that deregulation of SOX-11 
expression has effects on abnormally high levels of LINE ORF1-encoded protein 
observed in different tumors. Thus, the study of LINE-1 retrotransposition mediated 
by SOX-11 will shed light both on brain neurogenesis and on tumor progression 
processes. 
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Figure legends 
 
Figure 1. LINE-1 is activated during neuronal differentiation of SH-SY5H cells. A. 
Schematic sequence of LINE-1 showing the regions of annealing of the primers used 
in this study. 5´UTR is the 5´untranslated region, while ORF1 encodes a nucleic acid 
binding protein and ORF2 encodes an endonuclease with reverse transcriptase 
activity.B. RNA levels increase in neuroblastoma cells differentiating into neuron-like 
cells. SH-SY5H were grown in growth medium (CONTROL) or differentiation 
medium with retinoic acid (RA) for 48 h; RNA was collected and LINE-1 sequences 
quantified by RT-qPCR. Mean ± Standard error of the mean (SEM) values of LINE-1 
relative to ACTIN levels with n = 3 are shown. C. Similarly to B, after treatment with 
RA for 48 h, RNA was retrotranscribed with random hexamers and 3 LINE-1 
sequences were quantified by RT-qPCR: Orf-2 sequence, 5´ region and 3´ end. 
Mean ± SEM values of LINE-1 relative to ACTIN levels with n = 3 are shown. D. RA 
induces LINE-1 promoter activity. SH-SY5H cells were transiently transfected with a 
LINE-1 5´UTR reporter plasmid and -galactosidase vector. Then cells were 
incubated with vehicle (CONTROL) or RA for 48 h (RA). Mean ± SEM values of 
luciferase activity normalized to -gal with n = 3 are shown. E. SH-SY5H cells were 
stimulated with RA for 7 days; next, genomic DNA was collected and LINE-1 ORF2 
sequences were quantified by qPCR. Mean ± SEM values of LINE-1 relative to 
RNA5S levels with n = 6 are shown. In all cases, Student's t-tests were used. 
Figure 2. LINE-1 is activated during neuronal differentiation of hASCs. A. hASCs 
were grown in growth medium (CONTROL) or differentiation medium (DIF) for 14 
days; RNA was collected and LINE-1 sequences were quantified by RT-qPCR. Mean 
± SEM values of LINE-1 relative to ACTIN levels with n = 3 are shown. B. Genomic 
DNA was collected from control (CONTROL) hASCs or cells differentiated for 14 
days (DIF) and LINE-1 ORF2 sequences quantified qPCR. Mean ± SEM values of 
LINE-1 relative to RNA5S levels and normalized to control are shown, with * p< 0.05 
and n = 4. C. RNA levels remain unchanged in 293T and HeLa cells treated with RA. 
Cells were grown in growth medium (CONTROL) or differentiation medium with RA 
for 48 h (RA); LINE-1 RNA sequences were quantified by RT-qPCR. Mean ± SEM 
values of LINE-1 relative to ACTIN levels with n = 3 are shown. In all cases, 
Student's t-tests were used. 
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Figure 3. SOX-11 expression increases in neuronal differentiation conditions. A. SH-
SY5Y cells were challenged with RA (RA) or vehicle (CONTROL) for 24 h. Total 
RNA was collected and SOX-11 was quantified by RT-qPCR Mean ± SEM values of 
SOX-11 RNA levels normalized to ACTIN with n = 3 are shown. B. hASCs were 
cultured in growth medium (CONTROL) or in neuronal differentiation conditions (DIF) 
for 48 h. Then SOX-11 was quantified by RT-qPCR. Mean ± SEM values of SOX-11 
RNA levels normalized to ACTIN and normalized to control are shown, with * p< 0.05 
and n = 6. In all cases, Student's t-tests were used. 
Figure 4. Binding of SOX-11 to the LINE-1 5´UTR during neuronal differentiation. A. 
Schematic sequence of the 5´UTR showing two consensus SOX-11 binding sites, 
the upstream ATG codon, and the binding sites of the 2 primer pairs used in the 
study. B. ChIP-qPCR for SOX-11 in SH-SY5Y cells treated with RA for 24 h, using 
primers for the two sequences in the LINE-1 5´UTR amplified by primer pairs 1 and 
2, as described in A. Mean ± SEM values of % of input, with n = 3. In all cases, 
Student's t-tests were used. 
Figure 5. SOX-11 is necessary for LINE-1 activation during neuronal differentiation. 
SH-SY5Y cells were transfected with control scrambled siRNA (SCRAMBLE) or 
siRNA against SOX-11 (siRNA SOX-11). Next, cells were treated with RA (RA) or 
vehicle (CONTROL) for 48 h. A. RNA was collected and SOX-11 was quantified by 
RT-qPCR. Mean ± SEM values of SOX-11 RNA levels normalized to ACTIN with n = 
3 are shown. ANOVA followed by Tukey's multiple comparisons test was used. B. 
Similarly to A, mean ± SEM values of LINE-1 RNA levels normalized to ACTIN 
quantified by RT-qPCR are shown, with n = 3. ANOVA followed by Tukey's multiple 
comparisons test was used. C. The length of neurites and cell bodies of cells was 
measured and the percentage of cells exhibiting neurite outgrowth was estimated, 
considering cells as differentiated when the neurite/soma ratio was > 1.5. Mean ± 
SEM values of % of cells with neurite/soma ratio > 1.5 with n = 3 (including the 
averages of 3 fields in each case) are shown. * p < 0.05. Difference of proportions 
test was used. 
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